½ÃÀ庸°í¼­
»óǰÄÚµå
1786944

¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ - Á¦Ç°º°, ¿ëµµº°, ¼ö¹ýº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ½ÃÀå ¿¹Ãø(2025-2034³â)

Nutrigenomics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Kits and Services), By Application, By Technique, By End Use, By Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris market researchÀÇ ÃÖ±Ù Á¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 23¾ï 3,489¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¿µ¾çÀ¯ÀüüÇÐ »ê¾÷Àº °³ÀÎÀÇ À¯ÀüÀû üÁúÀÌ ¿µ¾ç¼Ò ¹× ½Ä»ç ¼ººÐ°ú ¾î¶»°Ô »óÈ£ÀÛ¿ëÇÏ¿© °Ç°­¿¡ ¿µÇâÀ» ¹ÌÄ¡´ÂÁö¸¦ ¿¬±¸ÇÕ´Ï´Ù. ÀÌ ºÎ¹®Àº °³ÀÎ °íÀ¯ÀÇ À¯ÀüÀÚ Á¤º¸¿¡ ¸Â´Â °³º° ¿µ¾ç °èȹ ¹× Á¦Ç°À» »ý»êÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ À¯ÀüÀÚ¿Í ¿µ¾ç¼ÒÀÇ »óÈ£ ÀÛ¿ëÀ» ÀÌÇØÇÔÀ¸·Î½á, ¿µ¾çÀ¯ÀüüÇÐÀº ÀüÅëÀûÀÎ ÀϹÝÀûÀÎ ½Ä´Ü Á¶¾ðº¸´Ù È¿°úÀûÀ¸·Î °Ç°­À» ÃÖÀûÈ­Çϰí Áúº´À» ¿¹¹æÇÏ¸ç ±âÁ¸ÀÇ ¸¸¼º ÁúȯÀ» °ü¸®ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ¿µ¾çÀ¯ÀüüÇÐÀº À¯ÀüüÇÐ, ¿µ¾çÇÐ, ºÐÀÚ»ý¹°Çп¡¼­ ¾òÀº Áö½ÄÀ» ÅëÇÕÇÏ¿© ´ÙÀÌ¾îÆ®¿Í ¶óÀÌÇÁ½ºÅ¸ÀÏ¿¡ ´ëÇÑ ¸Å¿ì ±¸Ã¼ÀûÀÎ Á¦¾ÈÀ» ÇÕ´Ï´Ù.

°³ÀÎÈ­µÈ °Ç°­ ¹× À£´Ï½º¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀǽÄÀº ¼¼°èÀûÀ¸·Î ³ô¾ÆÁö°í ÀÖÀ¸¸ç, 'ȹÀÏÀûÀÎ' ½ÄÀÌ ¿ä¹ý¿¡¼­ ¹þ¾î³ª¾ß ÇÕ´Ï´Ù. »ç¶÷µéÀº °³º° »ý¹°ÇÐÀû üÁúÀ» °í·ÁÇÑ ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Ãß±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº À¯ÀüÀÚ °Ë»ç ±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ ÁõÆøµÇ¾î, °³ÀÎÀÇ À¯ÀüÀÚ ºÐ¼® Á¤º¸¿¡ ´ëÇÑ ¾×¼¼½º°¡ º¸´Ù ½±°í Àú·ÅÇØÁö°í, ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñ¸¸, ´ç´¢º´, ½ÉÇ÷°ü Áúȯ µî ¸¸¼º ÁúȯÀÇ ¼¼°è À¯º´·ü »ó½Âµµ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿µ¾çÀ¯ÀüüÇÐÀº °³ÀÎÀÇ À¯ÀüÀû ¼ÒÀο¡ ±Ù°ÅÇÏ¿© ¾ö°ÝÇÑ ´ÙÀÌ¾îÆ® °³ÀÔÀ» Á¦°øÇÔÀ¸·Î½á ¿¹¹æ °Ç°­ °ü¸® ¹× Áúº´ °ü¸® °³¼±¿¡ À¯¸ÁÇÑ ±æÀ» ±âÀçÇϰí ÀÖ½À´Ï´Ù.

¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¿ëµµº°·Î´Â ¼¼°è ºñ¸¸ ¸¸¿¬ ¹× °³ÀÎÀÇ À¯Àü Á¤º¸¸¦ Ȱ¿ëÇÑ °³º°È­µÈ È¿°úÀûÀΠüÁß °ü¸® Àü·«¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä°¡ ³ô¾ÆÁü¿¡ µû¶ó ºñ¸¸ ºÎ¹®ÀÌ 2024³â¿¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Á¦Ç°º°·Î´Â 2024³â¿¡ ½Ã¾à ¹× ŰƮ ºÎ¹®ÀÌ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°Àº ¿µ¾çÀ¯ÀüüÇÐ ºÐ¼®À» ¼öÇàÇϱâ À§ÇÑ ±âÃʰ¡ µÇ±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ Á¦Ç°Àº DNA ÃßÃâ ŰƮ ¹× Á¦³ëŸÀÌÇΠŰƮ¿Í °°Àº °³ÀÎ ¹× ½ÇÇè½ÇÀÌ ¸ÂÃã ¿µ¾çÇÐÀû Áö½ÄÀ» À§ÇØ À¯ÀüÀÚ »ùÇÃÀ» ¼öÁý ¹× ó¸®Çϱâ À§ÇÑ Çʼö µµ±¸¸¦ Á¦°øÇÏ¸ç »ê¾÷ Àüü¸¦ Áö¿øÇÕ´Ï´Ù.

¼ö¹ýº°·Î´Â Ÿ¾× äÃë°¡ ºñħ½ÀÀûÀÌ°í Æí¸®¼ºÀÌ ³ô±â ¶§¹®¿¡ 2024³â ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ¹æ¹ýÀº Áý¿¡¼­ ½±°Ô »ùÇÃÀ» äÃëÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÓ»óÀÇ ÁøÂûÇÒ ¹ÞÀ» Çʿ䰡 ¾ø¾îÁ®, À¯ÀüÀÚ °Ë»ç°¡ º¸´Ù Æø³ÐÀº ¼ÒºñÀÚÃþ¿¡ À־ º¸´Ù Ä£¼÷ÇØÁö°Ô µÇ¾î, º¸±Þ¿¡ Å©°Ô °øÇåÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ 2024³â¿¡ ÃÖ´ëÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ÀüÅëÀûÀÎ ÇコÄɾî ȯ°æ¿¡¼­´Â ¿µ¾çÀ¯ÀüüÇÐ Áö½ÄÀ» ÁÖ¿ä ȯÀÚ Äɾ ÅëÇÕÇÏ´Â °æÇâÀÌ °­ÇØÁö°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ¼¼°èÀÇ ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ¹è°æ¿¡´Â °³ÀÎÈ­µÈ °Ç°­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ³ôÀº ÀǽÄ, °ß°íÇÑ ÇコÄɾî ÀÎÇÁ¶ó, À¯Àüü ¿¬±¸¿¡ ´ëÇÑ ¸¹Àº ÅõÀÚ°¡ ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¼¼°è ½ÃÀå¿¡¼­ ºü¸£°Ô È®´ëµÇ´Â Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¼ºÀåÀÇ ÁÖÀÎÀº °¡Ã³ºÐ ¼Òµæ Áõ°¡, ±¹¹ÎÀÇ °Ç°­ ÀÇ½Ä Áõ°¡, ºñ¸¸°ú ´ç´¢º´ µîÀÇ »ýȰ ½À°üº´¿¡ ÀÇÇÑ ºÎ´ãÀÇ Áõ´ëÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Nutrigenomix, Metagenics, Xcode Life, GX Sciences(Fagron), dnalife, Genova Diagnostics, Holistic Health International, Vitagene, Mapmygenome µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ ¹× ±âȸ
      • °³ÀÎÈ­µÈ °Ç°­ ¹× À£´Ï½º¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀÇ½Ä Çâ»ó
      • ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½Â
    • ¼ºÀå ¾ïÁ¦¿äÀÎ ¹× °úÁ¦
      • À¯Àüü °Ë»çÀÇ °íºñ¿ë
  • PESTEL ºÐ¼®
  • ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • ºñ¸¸
  • ½ÉÇ÷°ü Áúȯ
  • ¾Ï ¿¬±¸
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå : Á¦Ç°º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • ½Ã¾à ¹× ŰƮ
  • ¼­ºñ½º

Á¦7Àå ¼¼°èÀÇ ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå : ¼ö¹ýº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • Ÿ¾×
  • »´ Á¡¸· ¸éºÀ
  • Ç÷¾×

Á¦8Àå ¼¼°èÀÇ ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • º´¿ø ¹× Ŭ¸®´Ð
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
    • ¿µ¾çÀ¯ÀüüÇÐ ½ÃÀå Æò°¡ : Áö¿ªº°(2020-2034³â)
  • ºÏ¹Ì
    • ºÏ¹Ì : ¿ëµµº°(2020-2034³â)
    • ºÏ¹Ì : Á¦Ç°º°(2020-2034³â)
    • ºÏ¹Ì : ¼ö¹ýº°(2020-2034³â)
    • ºÏ¹Ì : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : ¿ëµµº°(2020-2034³â)
    • À¯·´ : Á¦Ç°º°(2020-2034³â)
    • À¯·´ : ¼ö¹ýº°(2020-2034³â)
    • À¯·´ : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç°º°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¼ö¹ýº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç°º°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¼ö¹ýº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç°º°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¼ö¹ýº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • È®´ë ¹× Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ, Çù¾÷, ÇÕÀÇ ¹× °ø°³

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Thermo Fisher Scientific
  • Dnalife
  • Genova Diagnostics
  • GX Sciences(Fagron)
  • Holistic Health International
  • Mapmygenome
  • Metagenics
  • Nutrigenomix
  • Vitagene(1Health.io)
  • Xcode Life
AJY 25.08.18

The global nutrigenomics market size is expected to reach USD 2,334.89 million by 2034, according to a new study by Polaris Market Research. The report "Nutrigenomics Market Size, Share, Trends, Industry Analysis Report: By Product (Reagents & Kits and Services), By Application, By Technique, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The nutrigenomics industry involves the study of how an individual's genetic makeup interacts with nutrients and dietary components to influence their health. This field aims to create personalized nutrition plans and products tailored to an individual's unique genetic information. By understanding these gene-nutrient interactions, nutrigenomics seeks to optimize health, prevent diseases, and manage existing chronic conditions more effectively than traditional, generalized dietary advice. It integrates insights from genomics, nutrition, and molecular biology to offer highly specific recommendations for diet and lifestyle.

There is a growing global awareness among consumers about personalized health and wellness, moving away from "one-size-fits-all" approaches to diet. People are increasingly seeking customized solutions that consider their individual biological makeup. This trend is amplified by advancements in genetic testing technologies, which have made it easier and more affordable to access personal genetic analysis information, which drives the nutrigenomics market growth. Furthermore, the rising prevalence of chronic diseases worldwide, such as obesity, diabetes, and cardiovascular conditions, is also fueling demand. Nutrigenomics offers a promising avenue for preventive healthcare and improved disease management by providing targeted dietary interventions based on an individual's genetic predispositions.

Nutrigenomics Market Report Highlights:

By application, the obesity segment held the largest share in 2024 due to the widespread global prevalence of obesity and the increasing consumer demand for personalized and effective weight management strategies that leverage individual genetic information.

By product, the reagents & kits segment held the largest share in 2024 as these products are fundamental to performing nutrigenomic analysis. They provide the essential tools, such as DNA extraction kits and genotyping kits, that enable individuals and laboratories to collect and process genetic samples for personalized nutritional insights, underpinning the entire industry.

By technique, saliva collection held the largest share in 2024 due to its noninvasive and highly convenient nature. This method allows for easy at-home sample collection, removing the need for clinical visits and making genetic testing more accessible to a broader consumer base, thus contributing significantly to its widespread adoption.

By end use, the hospitals & clinics segment held the largest share in 2024 as these traditional healthcare settings are increasingly integrating nutrigenomic insights into mainstream patient care.

By Region, North America held the largest share of the global nutrigenomics market in 2024. This is driven by high consumer awareness of personalized health, a robust healthcare infrastructure, and significant investments in genomic research.

Asia Pacific is emerging as a rapidly expanding region in the global market. This growth is primarily driven by rising disposable incomes, increasing health consciousness among the population, and a growing burden of lifestyle-related diseases such as obesity and diabetes.

A few key players in the market include Nutrigenomix, Metagenics, Xcode Life, GX Sciences (Fagron), dnalife, Genova Diagnostics, Holistic Health International, Vitagene, and Mapmygenome.

Polaris Market Research has segmented the nutrigenomics market report on the basis of application, product, technique, end use, and region:

By Application Outlook (Revenue - USD Million, 2020-2034)

Obesity

Cardiovascular Diseases

Cancer Research

Others

By Product Outlook (Revenue - USD Million, 2020-2034)

Reagents & Kits

Services

By Technique Outlook (Revenue - USD Million, 2020-2034)

Saliva

Buccal Swab

Blood

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals & Clinics

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Nutrigenomics Market Insights

  • 4.1. Nutrigenomics Market - Market Snapshot
  • 4.2. Nutrigenomics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Consumer Awareness of Personalized Health and Wellness
      • 4.2.1.2. Rising Prevalence of Chronic Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of genomic testing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Nutrigenomics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Nutrigenomics Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Nutrigenomics Market, by Application, 2020-2034 (USD Million)
  • 5.3. Obesity
    • 5.3.1. Global Nutrigenomics Market, by Obesity, by Region, 2020-2034 (USD Million)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Global Nutrigenomics Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Million)
  • 5.5. Cancer Research
    • 5.5.1. Global Nutrigenomics Market, by Cancer Research, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Nutrigenomics Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Nutrigenomics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Nutrigenomics Market, by Product, 2020-2034 (USD Million)
  • 6.3. Reagents & Kits
    • 6.3.1. Global Nutrigenomics Market, by Reagents & Kits, by Region, 2020-2034 (USD Million)
  • 6.4. Services
    • 6.4.1. Global Nutrigenomics Market, by Services, by Region, 2020-2034 (USD Million)

7. Global Nutrigenomics Market, by Technique

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
  • 7.3. Saliva
    • 7.3.1. Global Nutrigenomics Market, by Saliva, by Region, 2020-2034 (USD Million)
  • 7.4. Buccal Swab
    • 7.4.1. Global Nutrigenomics Market, by Buccal Swab, by Region, 2020-2034 (USD Million)
  • 7.5. Blood
    • 7.5.1. Global Nutrigenomics Market, by Blood, by Region, 2020-2034 (USD Million)

8. Global Nutrigenomics Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
  • 8.3. Hospitals & Clinics
    • 8.3.1. Global Nutrigenomics Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
  • 8.4. Others
    • 8.4.1. Global Nutrigenomics Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Nutrigenomics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Nutrigenomics Market Assessment, By Geography, 2020-2034 (USD Million)
  • 9.3. Nutrigenomics Market - North America
    • 9.3.1. North America: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
    • 9.3.2. North America: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
    • 9.3.3. North America: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
    • 9.3.4. North America: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.3.5. Nutrigenomics Market - US
      • 9.3.5.1. US: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.3.5.2. US: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.3.5.3. US: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.3.5.4. US: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.3.6. Nutrigenomics Market - Canada
      • 9.3.6.1. Canada: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.3.6.2. Canada: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.3.6.3. Canada: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.3.6.4. Canada: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
  • 9.4. Nutrigenomics Market - Europe
    • 9.4.1. Europe: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
    • 9.4.2. Europe: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
    • 9.4.3. Europe: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
    • 9.4.4. Europe: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.4.5. Nutrigenomics Market - UK
      • 9.4.5.1. UK: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.4.5.2. UK: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.4.5.3. UK: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.4.5.4. UK: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.4.6. Nutrigenomics Market - France
      • 9.4.6.1. France: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.4.6.2. France: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.4.6.3. France: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.4.6.4. France: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.4.7. Nutrigenomics Market - Germany
      • 9.4.7.1. Germany: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.4.7.2. Germany: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.4.7.3. Germany: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.4.7.4. Germany: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.4.8. Nutrigenomics Market - Italy
      • 9.4.8.1. Italy: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.4.8.2. Italy: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.4.8.3. Italy: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.4.8.4. Italy: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.4.9. Nutrigenomics Market - Spain
      • 9.4.9.1. Spain: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.4.9.2. Spain: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.4.9.3. Spain: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.4.9.4. Spain: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.4.10. Nutrigenomics Market - Netherlands
      • 9.4.10.1. Netherlands: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.4.10.2. Netherlands: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.4.10.3. Netherlands: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.4.10.4. Netherlands: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.4.11. Nutrigenomics Market - Russia
      • 9.4.11.1. Russia: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.4.11.2. Russia: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.4.11.3. Russia: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.4.11.4. Russia: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.4.12. Nutrigenomics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.4.12.2. Rest of Europe: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.4.12.3. Rest of Europe: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.4.12.4. Rest of Europe: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
  • 9.5. Nutrigenomics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
    • 9.5.2. Asia Pacific: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
    • 9.5.3. Asia Pacific: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
    • 9.5.4. Asia Pacific: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.5.5. Nutrigenomics Market - China
      • 9.5.5.1. China: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.5.5.2. China: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.5.5.3. China: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.5.5.4. China: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.5.6. Nutrigenomics Market - India
      • 9.5.6.1. India: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.5.6.2. India: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.5.6.3. India: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.5.6.4. India: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.5.7. Nutrigenomics Market - Malaysia
      • 9.5.7.1. Malaysia: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.5.7.2. Malaysia: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.5.7.3. Malaysia: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.5.7.4. Malaysia: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.5.8. Nutrigenomics Market - Japan
      • 9.5.8.1. Japan: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.5.8.2. Japan: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.5.8.3. Japan: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.5.8.4. Japan: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.5.9. Nutrigenomics Market - Indonesia
      • 9.5.9.1. Indonesia: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.5.9.2. Indonesia: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.5.9.3. Indonesia: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.5.9.4. Indonesia: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.5.10. Nutrigenomics Market - South Korea
      • 9.5.10.1. South Korea: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.5.10.2. South Korea: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.5.10.3. South Korea: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.5.10.4. South Korea: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.5.11. Nutrigenomics Market - Australia
      • 9.5.11.1. Australia: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.5.11.2. Australia: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.5.11.3. Australia: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.5.11.4. Australia: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.5.12. Nutrigenomics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
  • 9.6. Nutrigenomics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
    • 9.6.2. Middle East & Africa: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
    • 9.6.3. Middle East & Africa: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
    • 9.6.4. Middle East & Africa: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.6.5. Nutrigenomics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.6.5.2. Saudi Arabia: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.6.5.3. Saudi Arabia: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.6.5.4. Saudi Arabia: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.6.6. Nutrigenomics Market - UAE
      • 9.6.6.1. UAE: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.6.6.2. UAE: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.6.6.3. UAE: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.6.6.4. UAE: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.6.7. Nutrigenomics Market - Israel
      • 9.6.7.1. Israel: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.6.7.2. Israel: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.6.7.3. Israel: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.6.7.4. Israel: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.6.8. Nutrigenomics Market - South Africa
      • 9.6.8.1. South Africa: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.6.8.2. South Africa: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.6.8.3. South Africa: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.6.8.4. South Africa: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.6.9. Nutrigenomics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
  • 9.7. Nutrigenomics Market - Latin America
    • 9.7.1. Latin America: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
    • 9.7.2. Latin America: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
    • 9.7.3. Latin America: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
    • 9.7.4. Latin America: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.7.5. Nutrigenomics Market - Mexico
      • 9.7.5.1. Mexico: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.7.5.2. Mexico: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.7.5.3. Mexico: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.7.5.4. Mexico: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.7.6. Nutrigenomics Market - Brazil
      • 9.7.6.1. Brazil: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.7.6.2. Brazil: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.7.6.3. Brazil: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.7.6.4. Brazil: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.7.7. Nutrigenomics Market - Argentina
      • 9.7.7.1. Argentina: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.7.7.2. Argentina: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.7.7.3. Argentina: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.7.7.4. Argentina: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
    • 9.7.8. Nutrigenomics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Nutrigenomics Market, by Application, 2020-2034 (USD Million)
      • 9.7.8.2. Rest of Latin America: Nutrigenomics Market, by Product, 2020-2034 (USD Million)
      • 9.7.8.3. Rest of Latin America: Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
      • 9.7.8.4. Rest of Latin America: Nutrigenomics Market, by End Use, 2020-2034 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Thermo Fisher Scientific
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Dnalife
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Genova Diagnostics
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. GX Sciences (Fagron)
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Holistic Health International
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Mapmygenome
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Metagenics
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Nutrigenomix
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Vitagene (1Health.io)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Xcode Life
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦